Market Synopsis

Global Pharmaceutical Grade Lactose Market is anticipated to exhibit a CAGR of 4.76% to reach USD 278.604 Million from 2019 to 2025. The Pharmaceutical grade lactose is extremely pure lactose extensively produced to meet the standards of identity and purity set down.

Pharmaceutical grade lactose is created to meet rigid specifications, such as specific form and size distribution, monohydrate, crystalline, 40 mesh to 325 mesh, and a spray-dried mixture of crystalline and amorphous lactose for all applications.

Global Pharmaceutical Grade Lactose Market is expected to witness a healthy market growth owing to the rising demand for dry powder inhalers (DPI) products, compatibility with active ingredients and other excipients, and drug formulation coupled with nanotechnology. However, stringent government regulations and a lack of compatibility with amine-based drugs are expected to restrain the growth of the market during the review period.

Market Segmentation
Global Pharmaceutical Grade Lactose Market has been classified into Type and Application. Based on type segment the global has been categorized into crystalline monohydrate lactose, inhalation lactose, granulated lactose, spray-dried lactose, and others.

Crystalline Monohydrate Lactose has been further classified into α-Lactose monohydrate, and β-Lactose (anhydrous lactose). Whereas the Inhalation Lactose segment is further divided into Sieved and Milled.

In terms of the application segment, the global pharmaceutical grade lactose market has been classified into tablets manufacturing, capsule manufacturing, and others. The tablets manufacturing segment has been again divided into direct compression, wet granulation, and dry granulation. Capsule manufacturing is further classified into capsules, sachets, and others.

Regional Analysis
Geographically, the Global Pharmaceutical grade lactose market has been segmented into America, Europe, Asia-Pacific, and the Rest of the world.
Europe is expected to register the largest market share of the global pharmaceutical market owing to the presence of many major manufacturers and manufacturing associations in the region such as BASF Corporation, Merck KGaA, Kerry Inc., DFE Pharma, and others.

Asia-Pacific is expected to register as the second-largest market for Pharmaceutical grade lactose. As per the United Nations, across Asia, the number of people age 65 and above is expected to grow dramatically over the next 50 years. The population in this age group will increase by 314% from 207 million in 2000 to 857 million in 2050 in the region.

Americas is likely to exhibit the third-largest market for Pharmaceutical grade lactose due to the growing incidences of the population suffering from chronic obstructive pulmonary diseases (COPD). In 2018, approximately 9 million adults were diagnosed with chronic bronchitis in the US. COPD was the fourth leading cause of death in the US.

The Middle East and the rest of the world are anticipated to witness a rapidly expanding market in the Middle East and Africa owing to the increased prevalence of COPD and the existence of distributors and subsidiaries in the region.

Major Players
The Major Players of the Global Pharmaceutical Grade Lactose Market includes Kerry Inc. (Ireland), DFE Pharma (Germany), Meggle Excipients & Technology (Germany), Merck KGaA (Germany), Armor Pharma (France), ALPAVIT (Germany), BASF SE (Germany) and others.

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries.

Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Global Lactose-Free Butter Market Analysis and Forecast Report 2030

The post Global Pharmaceutical grade lactose Market Research Report- forecast till 2025 first appeared on CRI Report.

Key Findings
• The global sterility testing market is expected to reach USD 942.5 million by 2023 at a CAGR of 11.10% from 2018 to 2023.
• On the basis of test type, the membrane filtration segment accounted for the largest market share of 9.8% in 2017 and was valued at USD 350.7 million by 2023.
• The market in the Americas is expected to account for the largest share of the global sterility testing market and is projected to reach USD 520 million by 2023.
• The market in Asia-Pacific is projected to be the fastest-growing at a CAGR of 7.5% from 2018 to 2023.
Regional Analysis
• Americas
o North America
 US
 Canada
o Latin America
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa

The post Global Sterility Testing Market Research Report – Global Forecast Till 2023 first appeared on CRI Report.